XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis
Crossref DOI link: https://doi.org/10.1186/1477-9560-12-16
Published Online: 2014-07-14
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ageno, Walter
Mantovani, Lorenzo G
Haas, Sylvia
Kreutz, Reinhold
Haupt, Verena
Schneider, Jonas
Turpie, Alexander GG
Article History
Received: 11 February 2014
Accepted: 11 June 2014
First Online: 14 July 2014